Cj. Meurling et al., Attenuation of electrical remodelling in chronic atrial fibrillation following oral treatment with verapamil, EUROPACE, 1(4), 1999, pp. 234-241
Aims Electrical remodelling with shortening of the atrial refractory period
and increased fibrillatory rate occurs after onset of atrial fibrillation
and can be attenuated by pre-treatment with intravenous verapamil. The aim
of the present study was to investigate whether already established fibrill
atory-induced shortening of atrial fibrillatory cycle length could be rever
sed with oral verapamil.
Methods and Results Thirteen patients (nine men; mean age 67 years) with ch
ronic atrial fibrillation (CAF) were studied. The dominant atrial cycle len
gth (DACL) was estimated non-invasively using the frequency analysis of fib
rillatory ECG (FAF-ECG) method. Measurements were repeated following treatm
ent with slow release oral verapamil. DACL increased from 147 +/- 13 ms to
156 +/- 21 ms after 1 day (P=0.02), to 164 +/- 18 ms after 5 days (P=0.005)
and finally to 160 +/- 16 ms after 6 weeks (P=0.008).
Conclusion Long-term oral treatment with verapamil increases the DACL signi
ficantly in patients with CAF. The prolongation is evident after 1 day and
is further developed during the first 5 days of treatment. Since DACL is be
lieved to be an index of refractoriness, the findings of the present study
suggest that this treatment increases the atrial refractory period in patie
nts with CAF. (C) 1999 The European Society of Cardiology.